Atricure to participate in upcoming investor conferences

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in upcoming investor conferences. atricure's management is scheduled to participate in a fireside discussion at the ubs global healthcare conference on monday, november 10, 2025, at 2:00 pm eastern standard time. atric.
ATRC Ratings Summary
ATRC Quant Ranking